1. Home
  2. TECX vs HOV Comparison

TECX vs HOV Comparison

Compare TECX & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.07

Market Cap

554.1M

Sector

N/A

ML Signal

HOLD

Logo Hovnanian Enterprises Inc.

HOV

Hovnanian Enterprises Inc.

HOLD

Current Price

$106.67

Market Cap

595.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
HOV
Founded
2019
1959
Country
United States
United States
Employees
60
1891
Industry
Homebuilding
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
554.1M
595.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
HOV
Price
$29.07
$106.67
Analyst Decision
Strong Buy
Sell
Analyst Count
5
2
Target Price
$75.20
$97.00
AVG Volume (30 Days)
211.4K
101.4K
Earning Date
05-07-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.96
P/E Ratio
N/A
$17.50
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$85.69
52 Week High
$35.99
$162.06

Technical Indicators

Market Signals
Indicator
TECX
HOV
Relative Strength Index (RSI) 52.26 49.90
Support Level $27.39 $99.06
Resistance Level $31.17 $113.60
Average True Range (ATR) 1.82 5.98
MACD 0.08 0.37
Stochastic Oscillator 66.98 59.51

Price Performance

Historical Comparison
TECX
HOV

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.

Share on Social Networks: